| 1 |
33485453 | Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial. | 2021 Jan 23 |
2 |
| 2 |
33974709 | Gene-Gene Interactions of Gemcitabine Metabolizing-Enzyme Genes hCNT3 and WEE1 for Preventing Severe Gemcitabine-Induced Hematological Toxicity. | 2021 Oct |
4 |
| 3 |
34753061 | Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression. | 2021 Dec |
1 |
| 4 |
32180106 | Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine. | 2020 May |
1 |
| 5 |
31387179 | Enhancement of chemosensitivity by WEE1 inhibition in EGFR-TKIs resistant non-small cell lung cancer. | 2019 Sep |
2 |
| 6 |
29735549 | Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine. | 2018 Jun 1 |
2 |
| 7 |
29895190 | The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors. | 2018 |
1 |
| 8 |
25774168 | Targeting lung cancer through inhibition of checkpoint kinases. | 2015 |
1 |
| 9 |
25965828 | Wee1 is required to sustain ATR/Chk1 signaling upon replicative stress. | 2015 May 30 |
4 |
| 10 |
26057002 | WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients. | 2015 Jun 9 |
2 |
| 11 |
26585231 | Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair. | 2015 Oct |
2 |
| 12 |
23520471 | Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas. | 2013 |
1 |
| 13 |
19500427 | Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor. | 2009 Jun 8 |
1 |